Moving to the Mounjaro 7.5mg Injection: What This Step Means

You've just been told your next pen is the 7.5mg — here's what that actually means

A lot of people reach this point feeling quietly optimistic. The nausea that arrived with the 2.5mg starter has eased; the 5mg pen brought noticeable changes to appetite and the scale has been moving. So when a prescriber says the next step is 7.5mg, the natural question is: what's different this time?

The short answer is: more of the same mechanism, dialled up. Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) that reduce appetite, slow the rate at which food leaves the stomach, and influence blood-sugar regulation. At 7.5mg those signals are stronger than at 5mg, which is why the prescribing schedule allows four full weeks at each dose rather than rushing the increase. Your body needs time to settle.

In practice, people at 7.5mg often report that portion sizes they'd been managing without much effort suddenly feel genuinely large, and that the urge to snack between meals has quietened further. That's not a side effect, it's the medicine working. The therapeutic effect that the earlier doses were building towards starts to feel more established at this strength. For context on how the whole titration ladder fits together, the Mounjaro dose guide walks through each step from 2.5mg to 15mg.

One practical note: if your 7.5mg pen arrives just before a bank holiday or you order mid-month when payday timing means a short gap between pens, store it in the fridge at 2–8°C and check the Patient Information Leaflet for the exact room-temperature window if you need to take it out. Don't adjust your injection day without talking to your prescriber first.

Side effects at 7.5mg: what's normal, what to watch for

Moving to a higher dose is the moment side effects most often resurface, even for people who sailed through the earlier steps. Nausea is the most common, followed by looser stools, constipation, reflux and a general feeling of fullness that can tip into discomfort if you eat too quickly. For most people these settle within one to two weeks. Eating more slowly, keeping portions modest and staying well hydrated all help.

Fatigue and mild headache appear for some people after a dose increase too. These are usually brief. Injection-site reactions (a little redness or tenderness where you injected) are normal and generally resolve within a day or two. Rotating sites each week reduces the chance of a reaction building up.

The side effect worth knowing about in more detail is pancreatitis. It is uncommon, but the MHRA has highlighted it as a known risk with GLP-1 medicines: severe, persistent stomach pain that spreads towards the back, with or without vomiting, is a signal to stop the injection and seek urgent medical help rather than waiting to see if it passes. The MHRA Yellow Card scheme is also how patients can report any suspected side effect, it contributes to ongoing safety monitoring for medicines like tirzepatide.

If side effects at 7.5mg feel unmanageable, that is a conversation for your prescriber, not something to push through alone. Staying at the 5mg pen for longer is a legitimate clinical option; the schedule is a guide, not a deadline.

Whether 7.5mg is the right step for you is a clinical judgement

Tirzepatide is licensed in the UK for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, raised cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. But meeting the licence criteria doesn't automatically mean 7.5mg is your next move, the prescriber weighs how well the 5mg dose was tolerated, any ongoing side effects, and the clinical picture overall before approving an increase.

NICE's appraisal of tirzepatide, TA1026, recommends treatment to the highest dose the patient tolerates, not the highest dose on the list. That framing matters. The goal isn't 15mg; it's the dose where you're getting meaningful benefit without unnecessary discomfort. For some people, 7.5mg is that dose and they stay there. For others it's a stepping stone to the 10mg pen or beyond. The prescriber's job is to help you find it.

If you're considering starting Mounjaro privately and want to understand what the consultation covers, the weight-loss treatments page sets out how the assessment works. There's also broader context on what Mounjaro is and how it's used, if you're still weighing up the treatment itself rather than the dose.

The cost picture around this dose

Tirzepatide pens are priced per pen in the private market, and the 7.5mg pen is the same format as every other strength, one pen, four weekly injections. The Mounjaro pricing page covers what private treatment typically costs across the dose range and what a legitimate price should include: clinical review, prescription, and delivery. Eli Lilly revised UK list prices in September 2025, and private prices across providers have moved accordingly. What a price doesn't always include (consultation fees, aftercare support, clinical re-review before each repeat) is worth checking before committing to any provider, and the same applies whether you're looking at the 10mg strength or any other point on the titration schedule.

At nume, one transparent price covers the consultation, the prescription, the medicine and next-working-day DPD delivery. There is no subscription. Every repeat order is reviewed by a real prescriber before it goes out. If you'd like to explore whether Mounjaro is clinically suitable for you, speak to our prescribers through our free consultation, the same day, by a GPhC-registered Independent Prescriber who reads your answers personally.